Johnson & Johnson

137.48-2.28-1.63%Vol 11.05M1Y Perf 1.95%
Apr 7th, 2020 16:02
BID137.01 ASK137.48
Open139.86 Previous Close139.76
Pre-Market139.71 After-Market-
 -0.05 -0.04%  - -%
Target Price
158.15 
Analyst Rating
Moderate Buy 1.56
Potential %
15.03 
Finscreener Ranking
★+     43.42
Insiders Trans % 3/6/12 mo.
-50/-43/-25 
Value Ranking
★+     46.55
Insiders Value % 3/6/12 mo.
-99/-94/-90 
Growth Ranking
★★★+     55.38
Insiders Shares Cnt. % 3/6/12 mo.
-99/-93/-90 
Income Ranking
★★     43.26
Market Cap362.45B 
Earnings Rating
Sell
Price Range Ratio 52W %
62.46 
Earnings Date
14th Apr 2020

Today's Price Range

137.26142.03

52W Range

109.16154.50

5 Year PE Ratio Range

14.30310.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
6.58%
1 Month
-1.60%
3 Months
-3.60%
6 Months
4.96%
1 Year
1.95%
3 Years
11.88%
5 Years
42.76%
10 Years
158.01%

TickerPriceChg.Chg.%
JNJ137.48-2.2800-1.63
AAPL259.43-3.0400-1.16
GOOG1 186.51-0.4100-0.03
MSFT163.49-1.7800-1.08
XOM41.240.77001.90
WFC28.770.14000.49
FB168.833.28001.98
GE7.03-0.2000-2.77
JPM90.641.18001.32
Earnings HistoryEstimateReportedSurprise %
Q04 20191.861.881.08
Q03 20192.002.126.00
Q02 20192.422.586.61
Q01 20192.032.103.45
Q04 20181.951.971.03
Q03 20182.032.050.99
Q02 20182.062.101.94
Q01 20182.012.062.49
Earnings Per EndEstimateRevision %Trend
3/2020 QR2.11-9.05Negative
6/2020 QR1.90-17.03Negative
12/2020 FY8.81-2.97Negative
12/2021 FY9.49-4.43Negative
Next Report Date14th Apr 2020
Estimated EPS Next Report2.11
Estimates Count5
EPS Growth Next 5 Years %6.30
Volume Overview
Volume11.05M
Shares Outstanding2.64B
Trades Count122.33K
Dollar Volume1.91B
Avg. Volume10.62M
Avg. Weekly Volume11.63M
Avg. Monthly Volume16.41M
Avg. Quarterly Volume10.88M

Johnson & Johnson (NYSE: JNJ) closed at 139.76 per share at the end of the most recent trading day (a 4.17% change compared to the prior day closing price) with a volume of 14.99M shares and market capitalization of 362.45B. Is a component of S&P 500, Dow Jones 30, Russell 1000 indexes and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 135100 people. Johnson & Johnson CEO is Alex Gorsky.

The one-year performance of Johnson & Johnson stock is 1.95%, while year-to-date (YTD) performance is -4.19%. JNJ stock has a five-year performance of 42.76%. Its 52-week range is between 109.16 and 154.5, which gives JNJ stock a 52-week price range ratio of 62.46%

Johnson & Johnson currently has a PE ratio of 23.80, a price-to-book (PB) ratio of 5.95, a price-to-sale (PS) ratio of 5.94, a price to cashflow ratio of 15.40, a PEG ratio of 2.32, a ROA of 9.65%, a ROC of 17.01% and a ROE of 25.15%. The company’s profit margin is 18.32%, its EBITDA margin is 30.00%, and its revenue ttm is $62.04 Billion , which makes it $23.53 revenue per share.

Of the last four earnings reports from Johnson & Johnson, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.11 for the next earnings report. Johnson & Johnson’s next earnings report date is 14th Apr 2020.

The consensus rating of Wall Street analysts for Johnson & Johnson is Moderate Buy (1.56), with a target price of $158.15, which is +15.03% compared to the current price. The earnings rating for Johnson & Johnson stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Johnson & Johnson has a dividend yield of 2.72% with a dividend per share of $3.80 and a payout ratio of 70.00%.

Johnson & Johnson has a Buy technical analysis rating based on Technical Indicators (ADX : 29.26, ATR14 : 6.83, CCI20 : 126.72, Chaikin Money Flow : 0.12, MACD : -1.54, Money Flow Index : 60.17, ROC : 16.47, RSI : 55.14, STOCH (14,3) : 96.20, STOCH RSI : 1.00, UO : 62.48, Williams %R : -3.80), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Johnson & Johnson in the last 12-months were: Alex Gorsky (Option Excercise at a value of $0), Ashley McEvoy (Option Excercise at a value of $0), Hubert Joly (Buy at a value of $706 399), Jennifer L. Taubert (Option Excercise at a value of $0), Joaquin Duato (Option Excercise at a value of $0), Joseph J. Wolk (Option Excercise at a value of $0), Kathryn E. Wengel (Option Excercise at a value of $126 305), Kathryn E. Wengel (Sold 2 017 shares of value $284 538 ), Kathy Wengel (Option Excercise at a value of $126 305), Kathy Wengel (Sold 2 017 shares of value $284 538 ), Marillyn A. Hewson (Buy at a value of $419 040), Michael E. Sneed (Option Excercise at a value of $3 639 975), Michael E. Sneed (Sold 58 128 shares of value $8 683 568 ), Michael H. Ullmann (Option Excercise at a value of $0), Michael Sneed (Option Excercise at a value of $3 639 975), Michael Sneed (Sold 58 128 shares of value $8 683 568 ), Paulus Stoffels (Option Excercise at a value of $0), Peter M. Fasolo (Option Excercise at a value of $0), Robert J. Decker (Option Excercise at a value of $0), Thibaut Mongon (Option Excercise at a value of $1 738 618), Thibaut Mongon (Sold 39 224 shares of value $5 803 583 ), William D. Perez (Buy at a value of $63 843)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
11 (68.75 %)
9 (64.29 %)
9 (64.29 %)
Moderate Buy
1 (6.25 %)
1 (7.14 %)
1 (7.14 %)
Hold
4 (25.00 %)
4 (28.57 %)
4 (28.57 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.56
Moderate Buy
1.64
Moderate Buy
1.64

Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, close to half of total revenue is generated in the United States.

CEO: Alex Gorsky

Teplephone: +1 732 524-0400

Address: One Johnson & Johnson Plaza, New Brunswick 08933, NJ, USA

Number of employees: 135 100

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

51%49%

Bearish Bullish

54%46%

News

Stocktwits